Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation

NCT01349595 is registered in ClinicalTrials.gov with Mark Stegall as lead sponsor.

NCT NCT01349595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation
Lead sponsor
Mark Stegall
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2011
Completion date
March 31, 2015
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of transplanted kidney